North America’s Leading Role in Rare Disease Innovation
North America remains a major powerhouse in the global life sciences sector, providing robust financial support and clinical infrastructure to accelerate the development of orphan drugs. Within the global Spinal Muscular Atrophy Market, the United States and Canada lead the adoption of cutting-edge therapies due to their exceptionally well-funded medical networks and widespread implementation...
0 Комментарии 0 Поделились 2 Просмотры 0 предпросмотр